Table of Contents 1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered: Ranking by Abuse Deterrent Formulation Technologies Revenue 1.4 Market Analysis by Type 1.4.1 Global Abuse Deterrent Formulation Technologies Market Size Growth Rate by Type: 2020 VS 2026 1.4.2 Antidepressants 1.4.3 CNS Stimulants 1.4.4 Others 1.5 Market by Application 1.5.1 Global Abuse Deterrent Formulation Technologies Market Share by Application: 2020 VS 2026 1.5.2 Tablet 1.5.3 Capsule 1.5.4 Other 1.6 Study Objectives 1.7 Years Considered 2 Global Growth Trends by Regions 2.1 Abuse Deterrent Formulation Technologies Market Perspective (2015-2026) 2.2 Abuse Deterrent Formulation Technologies Growth Trends by Regions 2.2.1 Abuse Deterrent Formulation Technologies Market Size by Regions: 2015 VS 2020 VS 2026 2.2.2 Abuse Deterrent Formulation Technologies Historic Market Share by Regions (2015-2020) 2.2.3 Abuse Deterrent Formulation Technologies Forecasted Market Size by Regions (2021-2026) 2.3 Industry Trends and Growth Strategy 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Challenges 2.3.4 Porter’s Five Forces Analysis 2.3.5 Abuse Deterrent Formulation Technologies Market Growth Strategy 2.3.6 Primary Interviews with Key Abuse Deterrent Formulation Technologies Players (Opinion Leaders) 3 Competition Landscape by Key Players 3.1 Global Top Abuse Deterrent Formulation Technologies Players by Market Size 3.1.1 Global Top Abuse Deterrent Formulation Technologies Players by Revenue (2015-2020) 3.1.2 Global Abuse Deterrent Formulation Technologies Revenue Market Share by Players (2015-2020) 3.1.3 Global Abuse Deterrent Formulation Technologies Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.2 Global Abuse Deterrent Formulation Technologies Market Concentration Ratio 3.2.1 Global Abuse Deterrent Formulation Technologies Market Concentration Ratio (CR5 and HHI) 3.2.2 Global Top 10 and Top 5 Companies by Abuse Deterrent Formulation Technologies Revenue in 2019 3.3 Abuse Deterrent Formulation Technologies Key Players Head office and Area Served 3.4 Key Players Abuse Deterrent Formulation Technologies Product Solution and Service 3.5 Date of Enter into Abuse Deterrent Formulation Technologies Market 3.6 Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2015-2026) 4.1 Global Abuse Deterrent Formulation Technologies Historic Market Size by Type (2015-2020) 4.2 Global Abuse Deterrent Formulation Technologies Forecasted Market Size by Type (2021-2026) 5 Abuse Deterrent Formulation Technologies Breakdown Data by Application (2015-2026) 5.1 Global Abuse Deterrent Formulation Technologies Market Size by Application (2015-2020) 5.2 Global Abuse Deterrent Formulation Technologies Forecasted Market Size by Application (2021-2026) 6 North America 6.1 North America Abuse Deterrent Formulation Technologies Market Size (2015-2020) 6.2 Abuse Deterrent Formulation Technologies Key Players in North America (2019-2020) 6.3 North America Abuse Deterrent Formulation Technologies Market Size by Type (2015-2020) 6.4 North America Abuse Deterrent Formulation Technologies Market Size by Application (2015-2020) 7 Europe 7.1 Europe Abuse Deterrent Formulation Technologies Market Size (2015-2020) 7.2 Abuse Deterrent Formulation Technologies Key Players in Europe (2019-2020) 7.3 Europe Abuse Deterrent Formulation Technologies Market Size by Type (2015-2020) 7.4 Europe Abuse Deterrent Formulation Technologies Market Size by Application (2015-2020) 8 China 8.1 China Abuse Deterrent Formulation Technologies Market Size (2015-2020) 8.2 Abuse Deterrent Formulation Technologies Key Players in China (2019-2020) 8.3 China Abuse Deterrent Formulation Technologies Market Size by Type (2015-2020) 8.4 China Abuse Deterrent Formulation Technologies Market Size by Application (2015-2020) 9 Japan 9.1 Japan Abuse Deterrent Formulation Technologies Market Size (2015-2020) 9.2 Abuse Deterrent Formulation Technologies Key Players in Japan (2019-2020) 9.3 Japan Abuse Deterrent Formulation Technologies Market Size by Type (2015-2020) 9.4 Japan Abuse Deterrent Formulation Technologies Market Size by Application (2015-2020) 10 Southeast Asia 10.1 Southeast Asia Abuse Deterrent Formulation Technologies Market Size (2015-2020) 10.2 Abuse Deterrent Formulation Technologies Key Players in Southeast Asia (2019-2020) 10.3 Southeast Asia Abuse Deterrent Formulation Technologies Market Size by Type (2015-2020) 10.4 Southeast Asia Abuse Deterrent Formulation Technologies Market Size by Application (2015-2020) 11 India 11.1 India Abuse Deterrent Formulation Technologies Market Size (2015-2020) 11.2 Abuse Deterrent Formulation Technologies Key Players in India (2019-2020) 11.3 India Abuse Deterrent Formulation Technologies Market Size by Type (2015-2020) 11.4 India Abuse Deterrent Formulation Technologies Market Size by Application (2015-2020) 12 Central & South America 12.1 Central & South America Abuse Deterrent Formulation Technologies Market Size (2015-2020) 12.2 Abuse Deterrent Formulation Technologies Key Players in Central & South America (2019-2020) 12.3 Central & South America Abuse Deterrent Formulation Technologies Market Size by Type (2015-2020) 12.4 Central & South America Abuse Deterrent Formulation Technologies Market Size by Application (2015-2020) 13 Key Players Profiles 13.1 Acura Pharmaceuticals 13.1.1 Acura Pharmaceuticals Company Details 13.1.2 Acura Pharmaceuticals Business Overview and Its Total Revenue 13.1.3 Acura Pharmaceuticals Abuse Deterrent Formulation Technologies Introduction 13.1.4 Acura Pharmaceuticals Revenue in Abuse Deterrent Formulation Technologies Business (2015-2020)) 13.1.5 Acura Pharmaceuticals Recent Development 13.2 Altus Formulation 13.2.1 Altus Formulation Company Details 13.2.2 Altus Formulation Business Overview and Its Total Revenue 13.2.3 Altus Formulation Abuse Deterrent Formulation Technologies Introduction 13.2.4 Altus Formulation Revenue in Abuse Deterrent Formulation Technologies Business (2015-2020) 13.2.5 Altus Formulation Recent Development 13.3 BioDelivery Sciences International 13.3.1 BioDelivery Sciences International Company Details 13.3.2 BioDelivery Sciences International Business Overview and Its Total Revenue 13.3.3 BioDelivery Sciences International Abuse Deterrent Formulation Technologies Introduction 13.3.4 BioDelivery Sciences International Revenue in Abuse Deterrent Formulation Technologies Business (2015-2020) 13.3.5 BioDelivery Sciences International Recent Development 13.4 Teva Pharmaceutical 13.4.1 Teva Pharmaceutical Company Details 13.4.2 Teva Pharmaceutical Business Overview and Its Total Revenue 13.4.3 Teva Pharmaceutical Abuse Deterrent Formulation Technologies Introduction 13.4.4 Teva Pharmaceutical Revenue in Abuse Deterrent Formulation Technologies Business (2015-2020) 13.4.5 Teva Pharmaceutical Recent Development 13.5 Elysium Therapeutics 13.5.1 Elysium Therapeutics Company Details 13.5.2 Elysium Therapeutics Business Overview and Its Total Revenue 13.5.3 Elysium Therapeutics Abuse Deterrent Formulation Technologies Introduction 13.5.4 Elysium Therapeutics Revenue in Abuse Deterrent Formulation Technologies Business (2015-2020) 13.5.5 Elysium Therapeutics Recent Development 13.6 Grünenthal 13.6.1 Grünenthal Company Details 13.6.2 Grünenthal Business Overview and Its Total Revenue 13.6.3 Grünenthal Abuse Deterrent Formulation Technologies Introduction 13.6.4 Grünenthal Revenue in Abuse Deterrent Formulation Technologies Business (2015-2020) 13.6.5 Grünenthal Recent Development 13.7 Intellipharmaceutics 13.7.1 Intellipharmaceutics Company Details 13.7.2 Intellipharmaceutics Business Overview and Its Total Revenue 13.7.3 Intellipharmaceutics Abuse Deterrent Formulation Technologies Introduction 13.7.4 Intellipharmaceutics Revenue in Abuse Deterrent Formulation Technologies Business (2015-2020) 13.7.5 Intellipharmaceutics Recent Development 13.8 Purdue Pharma 13.8.1 Purdue Pharma Company Details 13.8.2 Purdue Pharma Business Overview and Its Total Revenue 13.8.3 Purdue Pharma Abuse Deterrent Formulation Technologies Introduction 13.8.4 Purdue Pharma Revenue in Abuse Deterrent Formulation Technologies Business (2015-2020) 13.8.5 Purdue Pharma Recent Development 13.9 TITAN Pharmaceuticals 13.9.1 TITAN Pharmaceuticals Company Details 13.9.2 TITAN Pharmaceuticals Business Overview and Its Total Revenue 13.9.3 TITAN Pharmaceuticals Abuse Deterrent Formulation Technologies Introduction 13.9.4 TITAN Pharmaceuticals Revenue in Abuse Deterrent Formulation Technologies Business (2015-2020) 13.9.5 TITAN Pharmaceuticals Recent Development 14 Analyst's Viewpoints/Conclusions 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.2 Data Source 15.2 Disclaimer 15.3 Author Details

List of Tables Table 1. Abuse Deterrent Formulation Technologies Key Market Segments Table 2. Key Players Covered: Ranking by Abuse Deterrent Formulation Technologies Revenue Table 3. Ranking of Global Top Abuse Deterrent Formulation Technologies Manufacturers by Revenue (US$ Million) in 2019 Table 4. Global Abuse Deterrent Formulation Technologies Market Size Growth Rate by Type (US$ Million): 2020 VS 2026 Table 5. Key Players of Antidepressants Table 6. Key Players of CNS Stimulants Table 7. Key Players of Others Table 8. Global Abuse Deterrent Formulation Technologies Market Size Growth by Application (US$ Million): 2020 VS 2026 Table 9. Global Abuse Deterrent Formulation Technologies Market Size by Regions (US$ Million): 2020 VS 2026 Table 10. Global Abuse Deterrent Formulation Technologies Market Size by Regions (2015-2020) (US$ Million) Table 11. Global Abuse Deterrent Formulation Technologies Market Share by Regions (2015-2020) Table 12. Global Abuse Deterrent Formulation Technologies Forecasted Market Size by Regions (2021-2026) (US$ Million) Table 13. Global Abuse Deterrent Formulation Technologies Market Share by Regions (2021-2026) Table 14. Market Top Trends Table 15. Key Drivers: Impact Analysis Table 16. Key Challenges Table 17. Abuse Deterrent Formulation Technologies Market Growth Strategy Table 18. Main Points Interviewed from Key Abuse Deterrent Formulation Technologies Players Table 19. Global Abuse Deterrent Formulation Technologies Revenue by Players (2015-2020) (Million US$) Table 20. Global Abuse Deterrent Formulation Technologies Market Share by Players (2015-2020) Table 21. Global Top Abuse Deterrent Formulation Technologies Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Abuse Deterrent Formulation Technologies as of 2019) Table 22. Global Abuse Deterrent Formulation Technologies by Players Market Concentration Ratio (CR5 and HHI) Table 23. Key Players Headquarters and Area Served Table 24. Key Players Abuse Deterrent Formulation Technologies Product Solution and Service Table 25. Date of Enter into Abuse Deterrent Formulation Technologies Market Table 26. Mergers & Acquisitions, Expansion Plans Table 27. Global Abuse Deterrent Formulation Technologies Market Size by Type (2015-2020) (Million US$) Table 28. Global Abuse Deterrent Formulation Technologies Market Size Share by Type (2015-2020) Table 29. Global Abuse Deterrent Formulation Technologies Revenue Market Share by Type (2021-2026) Table 30. Global Abuse Deterrent Formulation Technologies Market Size Share by Application (2015-2020) Table 31. Global Abuse Deterrent Formulation Technologies Market Size by Application (2015-2020) (Million US$) Table 32. Global Abuse Deterrent Formulation Technologies Market Size Share by Application (2021-2026) Table 33. North America Key Players Abuse Deterrent Formulation Technologies Revenue (2019-2020) (Million US$) Table 34. North America Key Players Abuse Deterrent Formulation Technologies Market Share (2019-2020) Table 35. North America Abuse Deterrent Formulation Technologies Market Size by Type (2015-2020) (Million US$) Table 36. North America Abuse Deterrent Formulation Technologies Market Share by Type (2015-2020) Table 37. North America Abuse Deterrent Formulation Technologies Market Size by Application (2015-2020) (Million US$) Table 38. North America Abuse Deterrent Formulation Technologies Market Share by Application (2015-2020) Table 39. Europe Key Players Abuse Deterrent Formulation Technologies Revenue (2019-2020) (Million US$) Table 40. Europe Key Players Abuse Deterrent Formulation Technologies Market Share (2019-2020) Table 41. Europe Abuse Deterrent Formulation Technologies Market Size by Type (2015-2020) (Million US$) Table 42. Europe Abuse Deterrent Formulation Technologies Market Share by Type (2015-2020) Table 43. Europe Abuse Deterrent Formulation Technologies Market Size by Application (2015-2020) (Million US$) Table 44. Europe Abuse Deterrent Formulation Technologies Market Share by Application (2015-2020) Table 45. China Key Players Abuse Deterrent Formulation Technologies Revenue (2019-2020) (Million US$) Table 46. China Key Players Abuse Deterrent Formulation Technologies Market Share (2019-2020) Table 47. China Abuse Deterrent Formulation Technologies Market Size by Type (2015-2020) (Million US$) Table 48. China Abuse Deterrent Formulation Technologies Market Share by Type (2015-2020) Table 49. China Abuse Deterrent Formulation Technologies Market Size by Application (2015-2020) (Million US$) Table 50. China Abuse Deterrent Formulation Technologies Market Share by Application (2015-2020) Table 51. Japan Key Players Abuse Deterrent Formulation Technologies Revenue (2019-2020) (Million US$) Table 52. Japan Key Players Abuse Deterrent Formulation Technologies Market Share (2019-2020) Table 53. Japan Abuse Deterrent Formulation Technologies Market Size by Type (2015-2020) (Million US$) Table 54. Japan Abuse Deterrent Formulation Technologies Market Share by Type (2015-2020) Table 55. Japan Abuse Deterrent Formulation Technologies Market Size by Application (2015-2020) (Million US$) Table 56. Japan Abuse Deterrent Formulation Technologies Market Share by Application (2015-2020) Table 57. Southeast Asia Key Players Abuse Deterrent Formulation Technologies Revenue (2019-2020) (Million US$) Table 58. Southeast Asia Key Players Abuse Deterrent Formulation Technologies Market Share (2019-2020) Table 59. Southeast Asia Abuse Deterrent Formulation Technologies Market Size by Type (2015-2020) (Million US$) Table 60. Southeast Asia Abuse Deterrent Formulation Technologies Market Share by Type (2015-2020) Table 61. Southeast Asia Abuse Deterrent Formulation Technologies Market Size by Application (2015-2020) (Million US$) Table 62. Southeast Asia Abuse Deterrent Formulation Technologies Market Share by Application (2015-2020) Table 63. India Key Players Abuse Deterrent Formulation Technologies Revenue (2019-2020) (Million US$) Table 64. India Key Players Abuse Deterrent Formulation Technologies Market Share (2019-2020) Table 65. India Abuse Deterrent Formulation Technologies Market Size by Type (2015-2020) (Million US$) Table 66. India Abuse Deterrent Formulation Technologies Market Share by Type (2015-2020) Table 67. India Abuse Deterrent Formulation Technologies Market Size by Application (2015-2020) (Million US$) Table 68. India Abuse Deterrent Formulation Technologies Market Share by Application (2015-2020) Table 69. Central & South America Key Players Abuse Deterrent Formulation Technologies Revenue (2019-2020) (Million US$) Table 70. Central & South America Key Players Abuse Deterrent Formulation Technologies Market Share (2019-2020) Table 71. Central & South America Abuse Deterrent Formulation Technologies Market Size by Type (2015-2020) (Million US$) Table 72. Central & South America Abuse Deterrent Formulation Technologies Market Share by Type (2015-2020) Table 73. Central & South America Abuse Deterrent Formulation Technologies Market Size by Application (2015-2020) (Million US$) Table 74. Central & South America Abuse Deterrent Formulation Technologies Market Share by Application (2015-2020) Table 75. Acura Pharmaceuticals Company Details Table 76. Acura Pharmaceuticals Business Overview Table 77. Acura Pharmaceuticals Product Table 78. Acura Pharmaceuticals Revenue in Abuse Deterrent Formulation Technologies Business (2015-2020) (Million US$) Table 79. Acura Pharmaceuticals Recent Development Table 80. Altus Formulation Company Details Table 81. Altus Formulation Business Overview Table 82. Altus Formulation Product Table 83. Altus Formulation Revenue in Abuse Deterrent Formulation Technologies Business (2015-2020) (Million US$) Table 84. Altus Formulation Recent Development Table 85. BioDelivery Sciences International Company Details Table 86. BioDelivery Sciences International Business Overview Table 87. BioDelivery Sciences International Product Table 88. BioDelivery Sciences International Revenue in Abuse Deterrent Formulation Technologies Business (2015-2020) (Million US$) Table 89. BioDelivery Sciences International Recent Development Table 90. Teva Pharmaceutical Company Details Table 91. Teva Pharmaceutical Business Overview Table 92. Teva Pharmaceutical Product Table 93. Teva Pharmaceutical Revenue in Abuse Deterrent Formulation Technologies Business (2015-2020) (Million US$) Table 94. Teva Pharmaceutical Recent Development Table 95. Elysium Therapeutics Company Details Table 96. Elysium Therapeutics Business Overview Table 97. Elysium Therapeutics Product Table 98. Elysium Therapeutics Revenue in Abuse Deterrent Formulation Technologies Business (2015-2020) (Million US$) Table 99. Elysium Therapeutics Recent Development Table 100. Grünenthal Company Details Table 101. Grünenthal Business Overview Table 102. Grünenthal Product Table 103. Grünenthal Revenue in Abuse Deterrent Formulation Technologies Business (2015-2020) (Million US$) Table 104. Grünenthal Recent Development Table 105. Intellipharmaceutics Company Details Table 106. Intellipharmaceutics Business Overview Table 107. Intellipharmaceutics Product Table 108. Intellipharmaceutics Revenue in Abuse Deterrent Formulation Technologies Business (2015-2020) (Million US$) Table 109. Intellipharmaceutics Recent Development Table 110. Purdue Pharma Business Overview Table 111. Purdue Pharma Product Table 112. Purdue Pharma Company Details Table 113. Purdue Pharma Revenue in Abuse Deterrent Formulation Technologies Business (2015-2020) (Million US$) Table 114. Purdue Pharma Recent Development Table 115. TITAN Pharmaceuticals Company Details Table 116. TITAN Pharmaceuticals Business Overview Table 117. TITAN Pharmaceuticals Product Table 118. TITAN Pharmaceuticals Revenue in Abuse Deterrent Formulation Technologies Business (2015-2020) (Million US$) Table 119. TITAN Pharmaceuticals Recent Development Table 120. Research Programs/Design for This Report Table 121. Key Data Information from Secondary Sources Table 122. Key Data Information from Primary Sources List of Figures Figure 1. Global Abuse Deterrent Formulation Technologies Market Share by Type: 2020 VS 2026 Figure 2. Antidepressants Features Figure 3. CNS Stimulants Features Figure 4. Others Features Figure 5. Global Abuse Deterrent Formulation Technologies Market Share by Application: 2020 VS 2026 Figure 6. Tablet Case Studies Figure 7. Capsule Case Studies Figure 8. Other Case Studies Figure 9. Abuse Deterrent Formulation Technologies Report Years Considered Figure 10. Global Abuse Deterrent Formulation Technologies Market Size YoY Growth 2015-2026 (US$ Million) Figure 11. Global Abuse Deterrent Formulation Technologies Market Share by Regions: 2020 VS 2026 Figure 12. Global Abuse Deterrent Formulation Technologies Market Share by Regions (2021-2026) Figure 13. Porter's Five Forces Analysis Figure 14. Global Abuse Deterrent Formulation Technologies Market Share by Players in 2019 Figure 15. Global Top Abuse Deterrent Formulation Technologies Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Abuse Deterrent Formulation Technologies as of 2019 Figure 16. The Top 10 and 5 Players Market Share by Abuse Deterrent Formulation Technologies Revenue in 2019 Figure 17. North America Abuse Deterrent Formulation Technologies Market Size YoY Growth (2015-2020) (Million US$) Figure 18. Europe Abuse Deterrent Formulation Technologies Market Size YoY Growth (2015-2020) (Million US$) Figure 19. China Abuse Deterrent Formulation Technologies Market Size YoY Growth (2015-2020) (Million US$) Figure 20. Japan Abuse Deterrent Formulation Technologies Market Size YoY Growth (2015-2020) (Million US$) Figure 21. Southeast Asia Abuse Deterrent Formulation Technologies Market Size YoY Growth (2015-2020) (Million US$) Figure 22. India Abuse Deterrent Formulation Technologies Market Size YoY Growth (2015-2020) (Million US$) Figure 23. Central & South America Abuse Deterrent Formulation Technologies Market Size YoY Growth (2015-2020) (Million US$) Figure 24. Acura Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018 Figure 25. Acura Pharmaceuticals Revenue Growth Rate in Abuse Deterrent Formulation Technologies Business (2015-2020) Figure 26. Altus Formulation Total Revenue (US$ Million): 2019 Compared with 2018 Figure 27. Altus Formulation Revenue Growth Rate in Abuse Deterrent Formulation Technologies Business (2015-2020) Figure 28. BioDelivery Sciences International Total Revenue (US$ Million): 2019 Compared with 2018 Figure 29. BioDelivery Sciences International Revenue Growth Rate in Abuse Deterrent Formulation Technologies Business (2015-2020) Figure 30. Teva Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018 Figure 31. Teva Pharmaceutical Revenue Growth Rate in Abuse Deterrent Formulation Technologies Business (2015-2020) Figure 32. Elysium Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018 Figure 33. Elysium Therapeutics Revenue Growth Rate in Abuse Deterrent Formulation Technologies Business (2015-2020) Figure 34. Grünenthal Total Revenue (US$ Million): 2019 Compared with 2018 Figure 35. Grünenthal Revenue Growth Rate in Abuse Deterrent Formulation Technologies Business (2015-2020) Figure 36. Intellipharmaceutics Total Revenue (US$ Million): 2019 Compared with 2018 Figure 37. Intellipharmaceutics Revenue Growth Rate in Abuse Deterrent Formulation Technologies Business (2015-2020) Figure 38. Purdue Pharma Total Revenue (US$ Million): 2019 Compared with 2018 Figure 39. Purdue Pharma Revenue Growth Rate in Abuse Deterrent Formulation Technologies Business (2015-2020) Figure 40. TITAN Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018 Figure 41. TITAN Pharmaceuticals Revenue Growth Rate in Abuse Deterrent Formulation Technologies Business (2015-2020) Figure 42. Bottom-up and Top-down Approaches for This Report Figure 43. Data Triangulation Figure 44. Key Executives Interviewed

Acura Pharmaceuticals Altus Formulation BioDelivery Sciences International Teva Pharmaceutical Elysium Therapeutics Grünenthal Intellipharmaceutics Purdue Pharma TITAN Pharmaceuticals